Before you watch this webinar
Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.
Event
MS, fertility & pregnancy – a multidisciplinary perspective
Our sponsor
This webinar has been financially supported by sponsorship from Roche Products Limited. The first session in the webinar is designed and delivered by the MS Academy and sponsored by Roche Products Limited; the sponsor has had no input into the educational content or organisation of the session.
Overview
Navigating fertility and pregnancy in the context of multiple sclerosis (MS) requires thoughtful, evidence-based care — and often, multidisciplinary collaboration. This live webinar brings together a neurologist, an obstetrician, and a multiple sclerosis nurse specialist to share expert insights, clarify common misconceptions, and offer practical guidance for supporting individuals with MS throughout their reproductive journey.
Whether you’re a neurologist, MS nurse, GP, midwife, or allied health professional, this session is designed to enhance your knowledge, improve clinical confidence, and support collaborative care planning for patients considering pregnancy, already pregnant, or postpartum.
Understanding MS and Fertility:
- How MS may or may not affect fertility.
- Addressing misconceptions and concerns about getting pregnant with MS.
MS Medications and Pregnancy:
- The impact of MS medications on fertility and pregnancy.
- What medications are safe to continue during pregnancy and breastfeeding.
- When and how to manage medication adjustments before, during, and after pregnancy.
Pregnancy with MS:
- How MS may affect pregnancy and vice versa.
- Discussing the role of DMT's during pregnancy.
- Potential challenges in MS symptom management during pregnancy.
Presentation slides
Questions & answers from the webinar
Questions:
Do you have any advice or precautions for men with multiple sclerosis on disease modifying therapies whose partners wish to get pregnant?
Do you have any advice for men taking Teriflunomide if they are trying for a family - I recently asked a few colleagues and the advice given was varied?
Answer:
Disease modifying treatments and family planning in men with MS
Teriflunomide: No restrictions are required for men taking teriflunomide.
Cladribine: Men who have received cladribine treatment should take additional precautions to avoid
fathering a pregnancy for 6 months after their last dose
Fertility: There is no evidence of concern related to male fertility alongside disease modifying
treatments in multiple sclerosis on the date of this webinar. However, there is a general lack of evidence in this area.
Further information:
MS Society link:
What to know about MS and pregnancy
Paper:
Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research.
*Please note that all session and slide content are the views of the speakers, not the MS Academy.
The content of the recording is the speaker's personal opinion at the time of recording. Due to the
everchanging situation, advice given at the time of recording is subject to change.
Our sponsor
This webinar has been financially supported by sponsorship from Roche Products Limited. The first session in the webinar is designed and delivered by the MS Academy and sponsored by Roche Products Limited; the sponsor has had no input into the educational content or organisation of the session.
CPD accreditation
'MS, fertility & pregnancy – a multidisciplinary perspective' has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 1 category 1 (external) CPD credit(s).
Chair
Dr Kate PetheramConsultant neurologist, South Tyneside & Sunderland NHS Foundation Trust
Speakers
Daisy CamLead MS specialist nurse, Sheffield Teaching Hospitals NHS Foundation Trust
Dr Paarul PrinjaConsultant acute and obstetric physician & honorary consultant obstetric physician, New Cross Hospital, Royal Wolverhampton NHS Trust & Birmingham Women’s Hospital
Encouraging excellence, developing leaders, inspiring change
MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.